Delayed but effective induction of mucosal memory immune responses against genital HSV-2 in the absence of secondary lymphoid organs

Mucosal Immunology

Volumn 6, Issue 1, 2013, Pages 56-68

  Roth, K L ^a   Bhavanam, S ^a   Jiang, H ^a   Gillgrass, A ^a   Ho, K ^a   Ferreira, V H ^a   Kaushic, C ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LIVE VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; CD3+ T LYMPHOCYTE; CONTROLLED STUDY; FEMALE; GENITAL HERPES; HERPES SIMPLEX VIRUS 2; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOCOMPETENT CELL; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOPROPHYLAXIS; INFECTION RESISTANCE; LYMPHOCYTE COUNT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; VAGINAL SECRETION; VAGINITIS; VIRAL CLEARANCE; WILD TYPE;

EID: 84874052934     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2012.48     Document Type: Article

References (39)

1. Youngman, K. R., Lazarus, N. H. & Butcher, E. C. Lymphocyte homing: chemokines and adhesion molecules in T cella dn IgA plasma cell localization in the mucosal immune system. In Mucosal Immunology Vol 1 : (Mestecky, J.L.M., Strober, W., Bienenstock, J., McGhee, J.R. & Mayer, L., eds) 667-680 Elsevier, Burlington, MA, 2005.
2. Brandtzaeg, P. Function of mucosa-associated lymphoid tissue in antibody formation. Immunol. Invest. 39, 303-355 (2010).
3. Moyron-Quiroz, J. E. et al. Persistence and responsiveness of immunologic memory in the absence of secondary lymphoid organs. Immunity 25, 643-654 (2006). (Pubitemid 44529043)
4. Moyron-Quiroz, J. E. et al. Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity. Nat. Med. 10, 927-934 (2004). (Pubitemid 39273733)
5. Gillgrass, A. E., Tang, V. A., Towarnicki, K. M., Rosenthal, K. L. & Kaushic, C. Protection against genital herpes infection in mice immunized under different hormonal conditions correlates with induction of vaginaassociated lymphoid tissue. J. Virol. 79, 3117-3126 (2005). (Pubitemid 40270590)
6. Gillgrass, A. E., Fernandez, S. A., Rosenthal, K. L. & Kaushic, C. Estradiol regulates susceptibility following primary exposure to genital herpes simplex virus type 2, while progesterone induces inflammation. J. Virol. 79, 3107-3116 (2005). (Pubitemid 40270589)
7. Gommerman, J. L. & Browning, J. L. Lymphotoxin/light, lymphoid microenvironments and autoimmune disease. Nat. Rev. Immunol. 3, 642-655 (2003). (Pubitemid 37328667)
8. Tumanov, A. V. et al. Dissecting the role of lymphotoxin in lymphoid organs by conditional targeting. Immunol. Rev. 195, 106-116 (2003). (Pubitemid 37153457)
9. Tumanov, A. V., Kuprash, D. V. & Nedospasov, S. A. The role of lymphotoxin in development and maintenance of secondary lymphoid tissues. Cytokine Growth Factor Rev. 14, 275-288 (2003). (Pubitemid 36693147)
10. Alimzhanov, M. B. et al. Abnormal development of secondary lymphoid tissues in lymphotoxin beta-deficient mice. Proc. Natl. Acad. Sci. USA 94, 9302-9307 (1997).
11. Banks, T. A. et al. Lymphotoxin-alpha-deficient mice. Effects on secondary lymphoid organ development and humoral immune responsiveness. J. Immunol. 155, 1685-1693 (1995).
12. De Togni, P. et al. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science 264, 703-707 (1994). (Pubitemid 24185880)
13. Koni, P. A. et al. Distinct roles in lymphoid organogenesis for lymphotoxins alpha and beta revealed in lymphotoxin beta-deficient mice. Immunity 6, 491-500 (1997). (Pubitemid 27208204)
14. Berger, D. P. et al. Lymphotoxin-beta-deficient mice show defective antiviral immunity. Virology 260, 136-147 (1999). (Pubitemid 29391742)
15. Kumaraguru, U., Davis, I. A., Deshpande, S., Tevethia, S. S. & Rouse, B. T. Lymphotoxin alpha - /- mice develop functionally impaired CD8+ T cell responses and fail to contain virus infection of the central nervous system. J. Immunol. 166, 1066-1074 (2001). (Pubitemid 32060264)
16. Lee, B. J., Santee, S., Von Gesjen, S., Ware, C. F. & Sarawar, S. R. Lymphotoxin-alpha-deficient mice can clear a productive infection with murine gammaherpesvirus 68 but fail to develop splenomegaly or lymphocytosis. J. Virol. 74, 2786-2792 (2000). (Pubitemid 30117590)
17. Lund, F. E. et al. Lymphotoxin-alpha-deficient mice make delayed, but effective, T and B cell responses to influenza. J. Immunol. 169, 5236-5243 (2002). (Pubitemid 35217195)
18. Soderberg, K. A., Linehan, M. M., Ruddle, N. H. & Iwasaki, A. MAdCAM-1 expressing sacral lymph node in the lymphotoxin beta-deficient mouse provides a site for immune generation following vaginal herpes simplex virus-2 infection. J. Immunol. 173, 1908-1913 (2004). (Pubitemid 38971626)
19. Corey, L. & Wald, A. Genital herpes. In Sexually Transmitted Diseases (Holmes, K.K., Sparling, P.F., Mardh, P.A., Lemon, S.M., Stamm, W.E., Piot, P., et al., eds) 285-312, McGraw-Hill, New York, 1999.
20. Looker, K. J., Garnett, G. P. & Schmid, G. P. An estimate of global prevalence and incidence of herpes simplex virus type 2 infection. Bull. World Health Organ. 86, 737-816 (2008).
21. Cunningham, A. L. & Mikloska, Z. The Holy Grail: immune control of human herpes simplex virus infection and disease. Herpes 8 (Suppl 1), 6A - 10A (2001). (Pubitemid 32290369)
22. Koelle, D. M. & Corey, L. Recent progress in herpes simplex virus immunobiology and vaccine research. Clin. Micro. Rev. 16, 96-113 (2003). (Pubitemid 36114709)
23. Stanberry, L. R. et al. Glycoprotein-D-adjuvant vaccine to prevent genital herpes. N. Engl. J. Med. 347, 1652-1661 (2002). (Pubitemid 35340783)
24. Belshe, R. B. et al. Efficacy results of a trial of a herpes simplex vaccine. N. Engl. J. Med. 366, 34-43 (2012).
25. Kaushic, C. The role of the local microenvironment in regulating susceptibility and immune responses to sexually transmitted viruses in the female genital tract. J. Reprod. Immunol. 83, 168-172 (2009).
26. Kaushic, C., Roth, K. L., Anipindi, V. & Xiu, F. Increased prevalence of sexually transmitted viral infections in women: the role of female sex hormones in regulating susceptibility and immune responses. J. Reprod. Immunol. 88, 204-209 (2011).
27. Bhavanam, S., Snider, D. P. & Kaushic, C. Intranasal and subcutaneous immunization under the effect of estradiol leads to better protection against genital HSV-2 challenge compared to progesterone. Vaccine 26, 6165-6172 (2008).
28. Harandi, A. M., Svennerholm, B., Holmgren, J. & Eriksson, K. Protective vaccination against genital herpes simplex virus, type 2 infection in mice is associated with a rapid induction of local IFN-gamma-dependent RANTES production following a vaginal viral challenge. Am. J. Reprod. Immunol. 46, 420-424 (2001).
29. Harandi, A. M., Svennerholm, B., Holmgren, J. & Eriksson, K. Differential roles of B cells and IFN-gamma-secreting CD4(+) T cells in innate and adaptive immune control of genital herpes simplex virus type 2 infection in mice. J. Gen. Virol. 82 (Pt 4), 845-853 (2001). (Pubitemid 32280043)
30. Milligan, G. N., Bernstein, D. I. & Bourne, N. T lymphocytes are required for protection of the vaginal mucosa and sensory ganglia of immune mice against reinfection with herpes simplex virus type 2. J. Immunol. 160, 6093-6100 (1998). (Pubitemid 28298073)
31. Tang, V. A. & Rosenthal, K. L. Intravaginal infection with herpes simplex virus type-2 (HSV-2) generates a functional effector memory T cell population that persists in the murine genital tract. J. Reprod. Immunol. 87, 39-44 (2010).
32. Gillgrass, A., Chege, D., Bhavanam, S. & Kaushic, C. Estradiol limits viral replication following intravaginal immunization leading to diminished mucosal IgG response and non-sterile protection against genital herpes challenge. Am. J. Reprod. Immunol. 63, 299-309 (2010).
33. Johnson, A. J., Nelson, M. H., Bird, M. D., Chu, C. F. & Milligan, G. N. Herpes simplex virus (HSV)-specific T cells activated in the absence of IFN-gamma express alternative effector functions but are not protective against genital HSV-2 infection. J. Reprod. Immunol. 84, 8-15 (2010).
34. Parr, E. L. & Parr, M. B. Immunoglobulin G is the main protective antibody in mouse vaginal secretions after vaginal immunization with attenuated herpes simplex virus type 2. J. Virol. 71, 8109-8115 (1997). (Pubitemid 27446385)
35. Fu, Y. X. et al. Lymphotoxin-alpha (LTalpha) supports development of splenic follicular structure that is required for IgG responses. J. Exp. Med. 185, 2111-2120 (1997).
36. Parr, M. B. & Parr, E. L. Vaginal immunity in the HSV-2 mouse model. Int. Rev. Immunol. 22, 43-63 (2003). (Pubitemid 36164239)
37. Tengvall, S, Josefsson, A., Holmgren, J. & Harandi, A. M. CpG oligodeoxynucleotide augments HSV-2 glycoprotein D DNA vaccine efficacy to generate T helper 1 response and subsequent protection against primary genital herpes infection in mice. J. Reprod. Immunol. 68, 53-69 (2005). (Pubitemid 41739448)
38. Olson, K. et al. Liposomal gD ectodomain (gD1-306) vaccine protects against HSV2 genital or rectal infection of female and male mice. Vaccine 28, 548-560 (2009).
39. Gallichan, W. S., Gurasachi, T. & Rosenthal, K. L. Intranasal immunization with CpG oligonucleotides as an adjuvant dramatically increases IgA and protection against HSV-2 in the genital tract. J. Immunol. 166, 3451-3457 (2001). (Pubitemid 33117348)